← Back to search

ANI PHARMACEUTICALS, INC.

ANIP · NASDAQ

Biological Product (except Diagnostic) Manufacturing

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products.

ESG Scores

Overall ESG
3.9
Environmental
2.4
Social
2.2
Governance
6.2

Gender Diversity

Female Directors0.22219999999999998%
CEO GenderMale

Market Data

Price$81.73+0.81 (+1.00%)
Market Cap$1.81B
P/E Ratio23.13
EPS$—
52W High$99.50
52W Low$56.71
Beta0.49